CAPTRUST Financial Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.7K | Buy |
35,582
+2,398
| +7% | +$2.27K | ﹤0.01% | 2457 |
|
|
2025
Q1 | $15.3K | Buy |
33,184
+19,826
| +148% | +$9.14K | ﹤0.01% | 2329 |
|
|
2024
Q4 | $9.87K | Buy |
13,358
+2,008
| +18% | +$1.48K | ﹤0.01% | 2280 |
|
|
2024
Q3 | $17.8K | Buy |
11,350
+485
| +4% | +$761 | ﹤0.01% | 2262 |
|
|
2024
Q2 | $18.3K | Buy |
10,865
+54
| +0.5% | +$91 | ﹤0.01% | 2175 |
|
|
2024
Q1 | $25.9K | Sell |
10,811
-33,825
| -76% | -$81.2K | ﹤0.01% | 2108 |
|
|
2023
Q4 | $68.3K | Buy |
44,636
+18
| +0% | +$28 | ﹤0.01% | 2562 |
|
|
2023
Q3 | $48.6K | Sell |
44,618
-1,871
| -4% | -$2.04K | ﹤0.01% | 2481 |
|
|
2023
Q2 | $106K | Hold |
46,489
| – | – | ﹤0.01% | 2369 |
|
|
2023
Q1 | $113K | Buy |
+46,489
| New | +$113K | ﹤0.01% | 2142 |
|
|
2022
Q1 | – | Sell |
-1
| Closed | – | – | 5044 |
|
|
2021
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4849 |
|
|
2021
Q3 | – | Sell |
-1
| Closed | – | – | 4715 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4596 |
|
|
2021
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4429 |
|